A meta-analysis of genome-wide association studies of epigenetic age acceleration by Gibson, Jude et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A meta-analysis of genome-wide association studies of
epigenetic age acceleration
Citation for published version:
Gibson, J, Russ, T, Clarke, T-K, Howard, D, Hillary, R, Evans, K, Walker, R, Bermingham, M, Morris, S,
Campbell, A, Hayward, C, Murray, A, Porteous, D, Horvath, S, Lu, AT, McIntosh, A, Whalley, H & Marioni, R
2019, 'A meta-analysis of genome-wide association studies of epigenetic age acceleration', PLoS Genetics,
vol. 15, no. 11, e1008104. https://doi.org/10.1371/journal.pgen.1008104
Digital Object Identifier (DOI):
10.1371/journal.pgen.1008104
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
PLoS Genetics
Publisher Rights Statement:
This is an open access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source
are credited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
RESEARCH ARTICLE
A meta-analysis of genome-wide association
studies of epigenetic age acceleration
Jude GibsonID1, Tom C. RussID1,2,3,4, Toni-Kim Clarke1, David M. HowardID1, Robert
F. HillaryID5, Kathryn L. Evans4,5, Rosie M. WalkerID4,5, Mairead L. Bermingham5, Stewart
W. Morris5, Archie CampbellID5,6, Caroline HaywardID7, Alison D. Murray8, David
J. Porteous4,5, Steve HorvathID9,10, Ake T. LuID9, Andrew M. McIntoshID1,4, Heather
C. WhalleyID1, Riccardo E. Marioni4,5*
1 Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United
Kingdom, 2 Centre for Dementia Prevention, University of Edinburgh, Edinburgh, United Kingdom,
3 Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, United Kingdom,
4 Centre for Cognitive Ageing & Cognitive Epidemiology, University of Edinburgh, Edinburgh, United Kingdom,
5 Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of
Edinburgh, Edinburgh, United Kingdom, 6 Usher Institute for Population Health Sciences and Informatics,
University of Edinburgh, Edinburgh, United Kingdom, 7 MRC Human Genetics Unit, Institute of Genetics and
Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom, 8 Aberdeen Biomedical Imaging
Centre, University of Aberdeen, Aberdeen, United Kingdom, 9 Department of Human Genetics, David Geffen
School of Medicine, Los Angeles, CA, United States of America, 10 Department of Biostatistics, School of
Public Health, University of California-Los Angeles, Los Angeles, CA, United States of America
* riccardo.marioni@ed.ac.uk
Abstract
’Epigenetic age acceleration’ is a valuable biomarker of ageing, predictive of morbidity and
mortality, but for which the underlying biological mechanisms are not well established. Two
commonly used measures, derived from DNA methylation, are Horvath-based (Horvath-
EAA) and Hannum-based (Hannum-EAA) epigenetic age acceleration. We conducted
genome-wide association studies of Horvath-EAA and Hannum-EAA in 13,493 unrelated
individuals of European ancestry, to elucidate genetic determinants of differential epigenetic
ageing. We identified ten independent SNPs associated with Horvath-EAA, five of which are
novel. We also report 21 Horvath-EAA-associated genes including several involved in
metabolism (NHLRC, TPMT) and immune system pathways (TRIM59, EDARADD). GWAS
of Hannum-EAA identified one associated variant (rs1005277), and implicated 12 genes
including several involved in innate immune system pathways (UBE2D3, MANBA,
TRIM46), with metabolic functions (UBE2D3, MANBA), or linked to lifespan regulation
(CISD2). Both measures had nominal inverse genetic correlations with father’s age at
death, a rough proxy for lifespan. Nominally significant genetic correlations between Han-
num-EAA and lifestyle factors including smoking behaviours and education support the
hypothesis that Hannum-based epigenetic ageing is sensitive to variations in environment,
whereas Horvath-EAA is a more stable cellular ageing process. We identified novel SNPs
and genes associated with epigenetic age acceleration, and highlighted differences in the
genetic architecture of Horvath-based and Hannum-based epigenetic ageing measures.
Understanding the biological mechanisms underlying individual differences in the rate of epi-
genetic ageing could help explain different trajectories of age-related decline.
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Author summary
DNA methylation, an epigenetic process, is known to vary with age. Methylation levels at
specific sites across the genome can be combined to form estimates of age known as ‘epi-
genetic age’. The difference between epigenetic age and chronological age is referred to as
‘epigenetic age acceleration’, with positive values indicating that a person is biologically
older than their years. Understanding why some people seem to age faster than others
could shed light on the biological processes behind age-related decline; however, the
mechanisms underlying differential rates of epigenetic ageing are largely unknown. Here,
we investigate genetic determinants of two commonly used epigenetic age acceleration
measures, based on the Horvath and Hannum epigenetic clocks. We report novel genetic
variants and genes associated with epigenetic age acceleration, and highlight differences
in the genetic factors influencing these two measures. We identify ten genetic variants and
21 genes associated with Horvath-based epigenetic age acceleration, and one variant and
12 genes associated with the Hannum-based measure. There were no genome-wide signif-
icant variants or genes in common between the Horvath-based and Hannum-based mea-
sures, supporting the hypothesis that they represent different aspects of ageing. Our
results suggest a partial genetic basis underlying some previously reported phenotypic
associations.
Introduction
Ageing is associated with a decline in physical and cognitive health, and is the main risk factor
for many debilitating and life-threatening conditions including cardiovascular disease, cancer,
and neurodegeneration [1]. Ageing is a multi-dimensional construct, incorporating physical,
psychosocial, and biological changes. Everyone experiences the same rate of chronological age-
ing, but the rate of ‘biological ageing’, age-related decline in physiological functions and tis-
sues, differs between individuals. Various phenotypic and molecular biomarkers have been
used to study biological ageing, including a number of ’biological clocks’, the best known of
which is telomere length. Telomeres shorten with increasing age, and telomere length has been
found to predict morbidity and mortality [2]. More recently, research into epigenetics–chemi-
cal modifications to DNA without altering the genetic sequence–has yielded another method
for measuring biological age.
DNA methylation is an epigenetic modification, typically characterised by the addition of a
methyl group to a cytosine-guanine dinucleotide (CpG) [3], that can influence gene expression
and is associated with variation in complex phenotypes. This process is essential for normal
development and is associated with a number of key processes including ageing. DNA methyl-
ation levels are dynamic, varying with age across the life course [4,5] and are influenced by
both genetic and environmental factors [6].
Weighted averages of methylation at multiple CpG sites can be integrated into estimates of
chronological age referred to as ‘epigenetic age’. Two influential studies have used this method
to create ‘epigenetic clocks’, which accurately predict chronological age in humans. Hannum
et al. used DNA methylation profiles from whole blood from two cohorts to identify 71 CpG
sites that could be used to generate an estimate of age [7], while Horvath used data from 51 dif-
ferent tissue types from multiple studies to identify 353 CpG sites whose methylation levels
can be combined to form an age predictor [8]. Hannum et al.’s clock is specific to blood sam-
ples, although it can be adjusted for different tissue types using linear models. The Horvath
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clock is widely applicable, with the same CpG set and the same algorithm being used irrespec-
tive of the DNA source.
Although similar penalised regression models were used to select the CpG sites to be
included in each of these epigenetic clocks, there is limited overlap in the CpGs included. The
two measures are clearly related, but are thought to capture slightly different aspects of the
biology of ageing [9]. The Hannum age estimator correlates with proportions of certain blood
cells, reflecting its construction based on blood methylation data [9,10], and it is considered to
track aspects of immunosenescence. The pan-tissue Horvath clock, constructed across a broad
spectrum of tissue and cell types, is relatively uncorrelated with blood cell proportions [11],
and is thought to capture cell-intrinsic changes in DNA methylation which might reflect an
innate ageing process.
Both the Hannum and Horvath epigenetic clocks are strongly correlated (r>0.95) with
chronological age [7,8]. However, despite these high overall correlations, there can be substan-
tial differences between epigenetic and chronological age at the individual level, and it is
unclear what drives these differences. A greater epigenetic age relative to chronological age is
commonly described as ‘epigenetic age acceleration’ (EAA), and implies that a person is bio-
logically older than their years. EAA has been shown to be informative for both current and
future health trajectories [9]. Recently, a growing number of studies have used EAA to investi-
gate age-related disorders, and the epigenetic clock is increasingly being recognised as a valu-
able marker of biological ageing [10,12].
The simplest definition of epigenetic age acceleration is the residual that results from
regressing epigenetic age on chronological age. However, it is well known that the abundance
of different cell types in the blood changes with age [13,14], and hence two broad categories of
EAA measures have been distinguished: those that are independent of age-related changes in
blood cell composition, and those that incorporate and are enhanced by blood cell count infor-
mation [10]. The former group, considered to reflect ‘pure’ epigenetic ageing effects that are
not influenced by differences in blood cell counts, are often referred to as ‘intrinsic’ epigenetic
age measures. The latter group up-weights the contributions of blood cell counts, thus leverag-
ing known age-related changes to blood cell proportions to capture aspects of immunosenes-
cence; these measures are referred to as ‘extrinsic’ epigenetic age measures.
In keeping with previous work, this study focuses on two different epigenetic age measures,
based on the Horvath and Hannum epigenetic clocks [7,8], and uses these to derive variations
of EAA that are either independent of blood cell counts, or enhanced by changes in blood cell
composition. Horvath-based epigenetic age follows the approach by Horvath (2013), and is
defined as the predicted value of age based on the DNA methylation levels of the 353 CpG sites
identified in his study [8]. Horvath-based epigenetic age acceleration (Horvath-EAA) is the
residual term of a multivariate model regressing the Horvath-based epigenetic age estimate on
chronological age and estimates of blood cell counts. It is by definition independent of both
chronological age and age-related changes in the cellular composition of blood. Hannum-
based epigenetic age is based on DNA methylation levels at the 71 CpGs identified by Hannum
et al. (2013) [7]. Hannum-based epigenetic age acceleration (Hannum-EAA) is an enhanced
version of the Hannum estimate which up-weights the contributions of age-associated blood
cells. A weighted average of Hannum-based epigenetic age with blood cells whose abundance
is known to change with age is calculated, and Hannum-EAA is then defined to be the residual
variation from a univariate model regressing the weighted DNA methylation age estimate on
chronological age. Hannum-EAA is independent of chronological age but in addition to cell-
intrinsic epigenetic changes it also tracks age-related changes in blood cells. Full details of the
calculation of Horvath-EAA and Hannum-EAA are given in S1 Text.
GWAS of epigenetic age acceleration
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Horvath-EAA, described in previous publications as ‘intrinsic’ epigenetic age acceleration
(IEAA), can be interpreted as a measure of cell-intrinsic ageing that exhibits preservation
across multiple tissues, appears unrelated to lifestyle factors, and probably indicates a funda-
mental cell ageing process that is largely conserved across cell types [8,10]. In contrast, Han-
num-EAA, referred to in previous studies as ‘extrinsic’ epigenetic age acceleration (EEAA),
can be considered a biomarker of immune system ageing, explicitly incorporating aspects of
immune system decline such as age-related changes in blood cell counts, correlating with life-
style and health-span related characteristics, and thus yielding a stronger predictor of all-cause
mortality [10,15].
It should be noted that as both the Horvath and Hannum epigenetic clocks correlate well
with age, in a population with a wide age range they are guaranteed to correlate with each
other. However, Horvath-based and Hannum-based epigenetic age acceleration estimates, i.e.
the degree of divergence of epigenetic age from chronological age, are not guaranteed to be
correlated.
Previous studies have identified relationships between epigenetic ageing and numerous
traits, including several age-related health outcomes, for example Alzheimer’s disease pathol-
ogy [16], cognitive impairment [16], and age at menopause [17]. Higher EAA has been associ-
ated with poorer measures of physical and cognitive fitness [9] and higher risk of all-cause
mortality [12]. Many associations are specific to either Horvath-EAA or Hannum-EAA, a dis-
cordance that may reflect the differences in the two estimates and supports the theory that
they represent different aspects of ageing [15,18,19].
While EAA has been associated with various markers of physical and mental fitness, the
mechanisms underlying epigenetic ageing remain largely unknown. There has been little
research conducted thus far on genetic contributions to epigenetic age acceleration. However,
Lu et al. (2018) recently published results of the first genome-wide association analysis of
blood EAA in a sample of 9,907 individuals, identifying five genetic loci associated with Hor-
vath-EAA and three Hannum-EAA-associated loci [20].
This current study, with a sample size of 13,493 individuals, constitutes the largest study
of the genetic determinants of DNA methylation-based ageing to date. Single nucleotide
polymorphism (SNP)-based and gene-based approaches were used to identify genes and
loci associated with Hannum-based and Horvath-based estimates of EAA. Functional map-
ping and annotation of genetic associations were performed, alongside gene-based and
gene-set analyses, in an attempt to elucidate the genes and pathways implicated in differen-
tial rates of epigenetic ageing between individuals and shed light on the underlying biologi-
cal mechanisms. We report novel SNPs and genes associated with epigenetic age
acceleration, and highlight differences in the genetic architectures of the Horvath-based
and Hannum-based EAA measures.
Results
Estimation of epigenetic age and epigenetic age acceleration in the
Generation Scotland sample
A summary of the estimated epigenetic age variables in Generation Scotland (GS) is given in
S1 Table. Both the Horvath- and Hannum-based estimates of biological age were highly corre-
lated with chronological age (r = 0.94, SE = 0.005 and r = 0.93, SE = 0.005 respectively). The
two DNA methylation age estimates were also highly correlated with each other (r = 0.93,
SE = 0.005); however, the two estimates of epigenetic age acceleration, Horvath-EAA and Han-
num-EAA, were only weakly correlated (r = 0.30, SE = 0.013) (Fig 1).
GWAS of epigenetic age acceleration
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Fig 1. Scatter plots of A) Horvath-based epigenetic age versus Hannum-based epigenetic age, and B) Horvath-EAA vs
Hannum-EAA, for the Generation Scotland sample.
https://doi.org/10.1371/journal.pgen.1008104.g001
GWAS of epigenetic age acceleration
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GWAS of Horvath-EAA and Hannum-EAA in GS and replication of
previously identified loci
The genome-wide association study (GWAS) for the GS cohort yielded two significant
(P<5x10-8) variants for Horvath-EAA, but no SNPs achieved genome-wide significance for
association with Hannum-EAA (minimum P-value 7.85x10-8) (S2 Table, full output available
online at https://doi.org/10.7488/ds/2631). There was a moderate genetic correlation between
the two traits in the GS sample (rG = 0.597, SE = 0.279), and both measures had high genetic
correlations with the previously reported findings of Lu et al. (rG = 0.724, SE = 0.312 and rG =
1.021, SE = 0.356 for Horvath-EAA and Hannum-EAA respectively). All the significant SNPs
from the Lu et al. analysis of Horvath-EAA had the same direction of effect in GS (S3 Table),
with one attaining genome-wide significance (rs143093668, P-value = 3.53x10-8; remaining
SNPs had P-values between 5.76x10-2 and 1.34x10-4). Two of the three significant SNPs from
Lu et al.’s GWAS of Hannum-EAA had the same direction of effect in GS, although not at
genome-wide significance levels in this smaller sample (P-values 1.76x10-3 and 1.75x10-4).
Miami plots demonstrating a comparison between the EAA SNP association profiles in the GS
and Lu et al. samples are shown in Fig 2 (Horvath-EAA) and Fig 3 (Hannum-EAA). Quantile-
quantile plots (QQ plots) for the GWAS of Horvath-EAA and Hannum-EAA in GS are shown
in S1 Fig.
GWAS meta-analysis
We conducted genome-wide association meta-analyses of Horvath-EAA and Hannum-EAA
using 13,493 European-ancestry individuals aged between ten and 98 years from 12 cohorts,
adjusting for sex. Manhattan plots for Horvath-EAA and Hannum-EAA are shown in Fig 4,
Fig 2. Miami plot for GWAS of Horvath-EAA in the GS and Lu et al. cohorts. SNP-based Miami plot comparing the results of genome-wide association analyses of
Horvath-based epigenetic age acceleration in GS (top, n = 5,100) and Lu et al. (bottom, n = 8393), with—log10 transformed P-values for each SNP plotted against
chromosomal location. The red line indicates the threshold for genome-wide significance (P<5×10−8) and the blue line for suggestive associations (P<1×10−5).
Independent significant SNPs are annotated.
https://doi.org/10.1371/journal.pgen.1008104.g002
GWAS of epigenetic age acceleration
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with QQ plots of the observed P-values versus those expected shown in Fig 5. We did not find
apparent evidence for genomic inflation in either the GS study (Horvath-EAA: genomic infla-
tion factor λGC = 1.017, Linkage Disequilibrium (LD) score regression intercept (SE) = 1.002
(0.007); Hannum-EAA: λGC = 1.023, intercept (SE) = 0.998 (0.006), S4 Table) or the meta-
analysis (Horvath-EAA: λGC = 1.035, intercept (SE) = 1.006 (0.008), Hannum-EAA: λGC =
1.044, intercept (SE) = 1.002 (0.007)); Lu et al. previously reported no evidence for genomic
inflation for any of the individual studies making up their meta-analysis [20].
We identified 439 variants with a genome-wide significant association (P<5×10−8) with
Horvath-EAA, of which ten were independent (r2<0.1 within a 250kb window). The signifi-
cantly associated variants mapped to nine genomic loci on six chromosomes (Table 1, full
details in S5 Table). Of the ten independent significant variants identified here, five were
novel, that is, not within ± 500 Kb of a significant variant (P<5×10−8) reported by Lu et al.
[20]. The novel findings were a SNP on chromosome 1q24.2 in the C1orf112 gene, three SNPs
on chromosome three, at 3q21.3 (nearest gene: GATA2-AS1), 3q22.3 in the PIK3CB gene, and
3q25.1 in the LINC01214 gene, and a SNP on chromosome 12q23.3 (nearest genes: RP11-
412D9.4 and TMEM263). The risk alleles at these loci conferred between 0.33 (SE = 0.054) and
1.34 (SE = 0.127) years higher Horvath-EAA (Table 1). These ten independent lead SNPs
showed complete sign concordance for association with Horvath-EAA across GS and the Lu
study (S6 Table). Comparing the genomic loci identified in the current study with the five
reported by Lu et al., only one locus that was previously reported was not identified at
genome-wide significance here (rs11706810 at 3q25.33, meta-analysis P-value 8.68x10-8). S2
Fig shows the regional association plots for the independent signals, visualised in LocusZoom
[21]. Of the ten independent SNPs achieving genome-wide significance, none associated with
any other phenotype in currently published GWAS available via the NHGRI-EBI catalog.
Fig 3. Miami plot for GWAS of Hannum-EAA in the GS and Lu et al. cohorts. SNP-based Miami plot comparing the results of genome-wide association analyses of
Hannum-based epigenetic age acceleration in GS (top, n = 5,100) and Lu et al. (bottom, n = 8393), with—log10 transformed P-values for each SNP plotted against
chromosomal location. The red line indicates the threshold for genome-wide significance (P<5×10−8) and the blue line for suggestive associations (P<1×10−5).
Independent significant SNPs are annotated.
https://doi.org/10.1371/journal.pgen.1008104.g003
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The Hannum-EAA GWAS meta-analysis identified 324 genome-wide significant
(P<5×10−8) associated variants mapping to a single genomic locus at 10p11.21 with one index
SNP (Fig 4, Table 1, full details of index SNP in S5 Table). ZNF25, a transcription factor
Fig 4. Manhattan plots for genome-wide meta-analyses (n = 13,493) of Horvath-based and Hannum-based epigenetic age acceleration. SNP-based Manhattan
plots for Horvath-EAA and Hannum-EAA, with—log10 transformed P-values for each SNP plotted against chromosomal location. The red line indicates the threshold
for genome-wide significance (P<5×10−8) and the blue line for suggestive associations (P<1×10−5). Independent significant variants are annotated.
https://doi.org/10.1371/journal.pgen.1008104.g004
GWAS of epigenetic age acceleration
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associated with osteoblast differentiation of human skeletal stem cells [22], is the closest gene
to this variant, at a distance of 20 Kb. At this Hannum-EAA-related locus, the risk allele con-
ferred 0.53 (SE = 0.070) years higher Hannum-EAA. We replicated two of the three variants
significantly associated with Hannum-EAA in the Lu et al. study; however, based on our
clumping criteria with r2<0.1, we report only one as an independent significant SNP. Condi-
tional analysis revealed no secondary signal at this locus. The third locus reported in the previ-
ous study was not associated at genome wide significance in this larger sample (P = 3.74x10-3).
A regional association plot for 10p11.21 is shown in S2J Fig.
Of the ten independent variants associated with Horvath-EAA, nine exhibited sign-consis-
tent associations with Hannum-EAA, of which five attained at least nominal significance with
association P-values less than 0.05 (most significant P = 6.9x10-5) (S7 Table). The single inde-
pendent SNP associated with Hannum-EAA also exhibited a nominal and sign-consistent
association with Horvath-EAA (P = 0.011).
Methylation quantitative trait loci
Multiple studies have found that individual genotypes at specific loci can influence patterns of
DNA methylation (e.g. [23,24]). These loci, referred to as methylation quantitative trait loci
(mQTL) can influence methylation across extended genomic regions [23,24], and may under-
lie some SNP-phenotype associations. To evaluate whether mQTL are driving the observed
associations between SNPs and epigenetic age acceleration in our analysis, we assessed whether
any of the independent significant SNPs from the Horvath-EAA and Hannum-EAA GWAS
meta-analysis are mQTL for any CpGs included in the Horvath or Hannum epigenetic clocks,
using the methylation quantitative trait loci database (mQTLdb, [25]).
The single Hannum-EAA genome-wide significant SNP, rs1005277, is an mQTL for 38 dif-
ferent CpGs across the five assessed time points (birth, childhood, adolescence, middle age,
Fig 5. QQ plots for the meta-analyses of Horvath-based and Hannum-based epigenetic age acceleration. Quantile-quantile plots for the
genome-wide meta-analyses of Horvath-EAA and Hannum-EAA, showing the expected distribution of GWAS test statistics, -log10(p), versus
the observed distribution.
https://doi.org/10.1371/journal.pgen.1008104.g005
GWAS of epigenetic age acceleration
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pregnancy). For 11 of these CpGs the mQTL is cis-acting (where the genetic variation occurs
close to the methylation site), while it acts in trans (where variation occurs elsewhere in the
genome) for the other 27 CpGs. None of these CpGs, however, are included in either the Hor-
vath or Hannum epigenetic clocks.
Nine of the ten Horvath-EAA independent significant SNPs are mQTL, for a total of 74 dif-
ferent CpGs in the mQTL database. Two of these CpGs, cg26297688 and cg01459453, are
included in the Horvath clock only, while one, cg22736354, intersects with both the Hannum
and Horvath clocks. Four of the Horvath-EAA SNPs are cis-acting mQTL for these clock
CpGs at multiple time points, with two SNPs acting as mQTL for the same CpG (S8 Table).
These results suggest a potential mechanism of action whereby these SNPs influence biological
ageing through their effect on methylation levels. A summary of the CpGs linked to each
mQTL is shown in S9 Table.
Heritability
In order to characterise the genetic contribution to accelerated epigenetic ageing, SNP-based
heritability was estimated using univariate LD score regression [26], which requires only
GWAS summary statistics rather than full genotype data. The SNP-based heritabilities of Hor-
vath-EAA and Hannum-EAA were estimated to be 0.154 (SE = 0.042) and 0.194 (SE = 0.040)
respectively (S4 Table), providing evidence for a genetic component to differential epigenetic
ageing rates. These figures are comparable to previous SNP-based heritability estimates but
lower than estimates based on pedigree relationships [20].
Table 1. Independent variants with a meta-analysis genome-wide significant association with Horvath-based or Hannum-based epigenetic age acceleration.
Phenotype Index SNP Chromosome Position A1/
A2
Freq Beta SE P-value Genea function Previously
reported
Horvath-
EAA
rs1011267 1q24.2 169677720 A/G 0.503 -0.327 0.054 1.579E-
09
C1orf112 intron variant novel
rs79070372 3q21.3 128510481 A/G 0.111 0.505 0.087 6.074E-
09
GATA2-AS1 non coding transcript
variant
novel
rs388649 3q22.3 138777967 A/T 0.495 -0.338 0.055 6.054E-
10
PIK3CB intron variant novel
rs6440667 3q25.1 150287063 C/G 0.161 0.440 0.075 4.28E-09 LINC01214 intron variant novel
rs2736099 5p15.33 1287225 A/G 0.367 0.373 0.061 8.58E-10 TERT intron variant yes
rs7744541 6p22.3 18104469 A/T 0.418 0.439 0.055 1.93E-15 intergenic variant yes
rs76244256 6p22.3 18140332 T/C 0.046 -1.341 0.127 6.231E-
26
TPMT intron variant yes
rs4712953 6p22.2 25671618 A/T 0.725 0.346 0.059 3.604E-
09
SCGN intron variant yes
rs10778517 12q23.3 106947886 T/G 0.565 0.335 0.054 4.46E-10 RP11-412D9.4/
TMEM263
unknown novel
rs62078811 17q22 55031815 A/G 0.218 -0.369 0.065 1.158E-
08
STXBP4 intron variant yes
Hannum-
EAA
rs1005277 10p11.21 37929331 A/C 0.301 0.533 0.070 2.173E-
14
unknown yes
Genome-wide significance defined as having a P-value of P<5x10-8. A1 and A2 refer to the reference allele and non-reference allele for the index SNP, respectively. Freq
(allele frequency), Beta (effect size), and SE (standard error of effect size) columns pertain to the reference allele, A1. Chromosome and position (in Mb) denote the
location of the index SNP, and are given with regards to the GRCh38 assembly.
a Genes are listed if located within +/- 10 kb of a listed SNP.
https://doi.org/10.1371/journal.pgen.1008104.t001
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SNP functional annotation
We used FUMA [27] to functionally annotate SNPs in LD (r2�0.6) with the independent sig-
nificant SNPs for each of the epigenetic age acceleration measures. For Horvath-EAA, this
resulted in functional annotation of 825 SNPs (S10 Table). The vast majority of the SNPs were
intergenic (44.85%) or intronic (47.88%), with only five (0.61%) exonic SNPs. 25 SNPs had
CADD (Combined Annotation Dependent Depletion) scores greater than 12.37, surpassing
the suggested threshold to be considered deleterious and thus providing evidence of pathoge-
nicity [28]. The highest CADD scores were found in three exonic SNPs: rs1800460 and
rs1142345 of TPMT and rs10949483 of NHLRC1 (CADD scores 28.40, 28.30 and 18.92 respec-
tively), indicating potentially deleterious protein effects. Six SNPs (rs413147, rs12631035,
rs9851887, rs12189658, rs6915893, rs12199316) had RegulomeDB scores below 2, suggesting
that variation at these SNPs is likely to affect gene expression [29]. Almost all SNPs (98.18%)
were in open chromatin regions.
For Hannum-EAA, functional annotation of 1,382 candidate SNPs indicated a high propor-
tion of intergenic SNPs (60.49%), while 11.79% were intronic and only three SNPs were
located in exons (S11 Table). 14 SNPs had CADD scores above 12.37, indicating that variation
at these SNPs is potentially deleterious. Although 42.04% of the SNPs were located in open
chromatin regions, there is little evidence that the Hannum-EAA-associated locus contains
regulatory regions, as analysis using RegulomeDB, which integrates a larger collection of regu-
latory information encompassing protein binding, motifs, expression quantitative trait loci
(eQTL), and histone modifications as well as chromatin structure, revealed only one SNP
(rs2474568) with a score below 2.
eQTL and colocalisation analysis
For each independent SNP associated with Horvath-EAA or Hannum-EAA, evidence of eQTL
was explored using the Genotype Tissue Expression (GTEx) v7 database [30]. Seven of the ten
independent significantly associated SNPs for Horvath-EAA were identified as potential eQTL
(S12 Table). Notably, rs388649 is associated with expression of ESYT3, which has a role in
lipid transport and metabolism pathways [31,32], expression of FAIM, which is associated
with apoptosis and autophagy [33], in a number of skin and brain tissues, and PIK3CB, which
regulates vital cell functions including proliferation and survival [34,35]. rs76244256, the vari-
ant most strongly associated with Horvath-EAA, shows eQTL evidence for NHLRC1 expres-
sion, which is associated with glycogen metabolism [36], across multiple tissues. We found no
evidence for the Hannum-EAA-associated SNP, rs1005277, regulating gene expression.
To further investigate the possibility that these SNPs act via regulating the expression of
genes, we carried out colocalisation analysis using a Bayesian statistical method implemented
in the ’coloc’ package in R [37], which uses an approximate Bayes factor to estimate the poste-
rior probability (PP) that a given variant is causal in both the GWAS and eQTL studies. We
integrated our GWAS data with cis-eQTL data from the eQTLGen Consortium (https://www.
eqtlgen.org/) [38] and analysed pairwise colocalisation within a +/- 200 kb window of each sig-
nificant SNP. These analyses provide no evidence that the effect of these SNPs on accelerated
epigenetic ageing is mediated through cis gene expression. There was no evidence for colocali-
sation of any Horvath-EAA or Hannum-EAA-associated SNP with cis-eQTL (PP for shared
causal variant 8.31x10-15–0.030, S13 Table). Rather, in all but one case, the results support the
hypothesis that there are two distinct causal variants affecting epigenetic age acceleration and
transcript levels in the region (PP>0.95). In the +/-200 kb region surrounding variant
rs2736099, there is strong evidence (PP>0.95) for a causal variant affecting gene expression,
but not EAA.
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Gene-based analysis
MAGMA (Multi-marker Analysis of GenoMic Annotation) v1.6 was used to identify gene-
level associations with each EAA measure [39]. SNPs were mapped to 17,798 protein coding
genes, with genome-wide significance defined at P = 0.05/17,798 = 2.809x10-6. A total of 21
genes attained genome-wide significance for association with Horvath-EAA (Table 2, full
details in S14 Table). As expected, many of these genes were located in the same regions as the
lead SNPs. Three genes at 6p22.3, NHLRC1, TPMT, and KDM1B, had the lowest P-values of
1.251x10-23, 4.639x10-23, and 7.68x10-11 respectively; all these genes are involved in metabo-
lism-related pathways [36,40,41]. Although containing no genome-wide significant SNPs,
3q25.33 appears to be an important genomic region for Horvath-EAA, with four significantly
Table 2. Results of MAGMA gene-based association analysis for Horvath-based and Hannum-based epigenetic age acceleration.
Phenotype Gene Chr N_SNPs P-value Function/related pathways
Horvath-EAA SELP 1 148 1.6883E-07 Immunoglobulin E responsiveness
EDARADD 1 516 4.2627E-07 Innate immune system, cytokine signalling in immune system
GATA2 3 72 1.0663E-07 Stem cell maintenance and hematopoietic development
ESYT3 3 93 6.5973E-07 Metabolism, lipid transport
CEP70 3 164 1.0891E-06 Organelle biogenesis and maintenance
FAIM 3 49 2.4177E-08 Apoptosis and autophagy; regulates B-cell signalling and differentiation
PIK3CB 3 175 2.52E-08 Coordinates cell functions e.g. proliferation, survival, migration
IFT80 3 150 1.2622E-07 Organelle biogenesis and maintenance; intraflagellar transport
SMC4 3 77 9.8909E-07 Changes in chromosome structure during mitotic segregation
TRIM59 3 105 1.7737E-07 Multifunctional regulator for innate immune signalling pathways
KPNA4 3 104 2.9437E-07 Cytokine signalling in immune system; protein transporter activity
TERT 5 90 4.0455E-08 Roles in ageing and apoptosis; regulation of telomerase.
NHLRC1 6 76 1.2512E-23 Clearance of toxic polyglucosan and protein aggregates; metabolism pathways
TPMT 6 151 4.6385E-23 Drug metabolism—cytochrome P450; thiopurine S methyltransferase activity
KDM1B 6 248 7.6758E-11 Metabolism of proteins, regulates histone lysing methylation
SCGN 6 202 3.8379E-10 Calcium binding protein; neuroscience, Ca, cAMP and lipid signalling pathways
TMEM72 10 123 1.1154E-06 Transmembrane protein
RFX4 12 299 9.4786E-07 Transcriptional regulatory network in embryonic stem cell
RIC8B 12 155 1.0988E-06 Can activate some G-alpha proteins; odorant signal transduction.
C12orf23/TMEM263 12 98 6.321E-09 Transmembrane protein
ZNF70 22 79 2.7934E-06 Transcriptional regulation; gene expression pathways
Hannum-EAA TRIM46 1 27 2.66E-06 Innate immune system; cytokine signalling in immune system
MUC1 1 15 7.33E-07 Cytokine signalling in immune system; bacterial infections in CF airways
MANBA 4 190 1.31E-06 Glycosaminoglycan metabolism; innate immune system
UBE2D3 4 154 1.19E-06 Metabolism of proteins; innate immune system
CISD2 4 54 1.18E-06 Regulator of autophagy; life span control; glucose/energy metabolism pathways
SLC9B1 4 217 2.56E-06 Sperm motility and fertility, ion channel transport
MTRNR2L7 10 52 5.20E-07 Neuroprotective and antiapoptotic factor
ZNF248 10 204 2.22E-07 Transcriptional regulation; gene expression pathways
ZNF25 10 99 1.23E-08 Transcriptional regulation; gene expression pathways
ZNF33A 10 159 8.29E-09 Transcriptional regulation; gene expression pathways
ZNF37A 10 146 3.79E-10 Transcriptional regulation; gene expression pathways
DNTT 10 131 2.51E-07 DNA double-strand break repair; hematopoietic cell lineage
Genome-wide significant results after Bonferroni correction for multiple testing (P<2.809x10-6) are reported. N_SNPs is the number of SNPs in the gene.
https://doi.org/10.1371/journal.pgen.1008104.t002
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associated genes including TRIM59 and KPNA4, which play roles in the immune system
[42,43]. Two further significant genes are FAIM and TERT, whose functions include apoptosis
and autophagy [33], and telomere length-associated ageing and apoptosis [44,45] respectively.
Twelve genes were significantly associated with Hannum-EAA (Table 2, S14 Table). Genes of
interest include MTRNR2L7, a neuroprotective and anti-apoptotic factor [46,47], and TRIM46
and MUC1, both located at 1q22, and which are involved with innate immune system path-
ways [42,48]. The 4q24 cytogenetic band houses several genes significantly associated with
Hannum-EAA: MANBA and UBE2D3 have metabolic and innate immune system functions
[32,49] while CISD2 regulates autophagy and is involved in life span control [50,51]. Compar-
ing the results of the gene-based association analyses of Horvath-based and Hannum-based
EAA, there was no overlap in significantly associated genes. Manhattan plots and QQ plots for
the gene-based analysis of both epigenetic age acceleration measures are shown in S3 Fig and
S4 Fig.
Gene-set and pathway analysis
Using a competitive test of enrichment implemented in MAGMA v1.6, we did not identify any
gene sets that were significantly associated with either Horvath-EAA or Hannum-EAA after
Bonferroni correction for multiple testing. S15 Table and S16 Table show the top 100 gene-
sets for Horvath-EAA and Hannum-EAA respectively.
Genetic correlations
Several large-scale cohort studies have previously reported phenotypic associations
between epigenetic age acceleration and a number of traits or health outcomes. To investi-
gate whether these observed associations may be partly due to shared genetic variants influ-
encing the traits, we conducted cross-trait LD score regression analysis of summary-level
data [52], implemented in the online software LD Hub [53], to determine genetic correla-
tions between Horvath-EAA/Hannum-EAA and a number of health and behavioural vari-
ables. The SNP-based genetic correlation between Horvath-EAA and Hannum-EAA was
0.571 (SE = 0.132, P = 1.605x10-5), suggesting a moderate overlap in the genetic factors
influencing these two measures of epigenetic age acceleration. Of the 218 other health and
behavioural traits investigated, none had a statistically significant genetic correlation
(PFDR<0.05) with either Horvath-EAA or Hannum-EAA after applying false discovery rate
correction (most significant correlation with Horvath-EAA: father’s age at death, PFDR =
0.160; with Hannum-EAA: waist-to-hip ratio, PFDR = 0.065). This correction, however,
may be overly conservative, as not all the tested traits are independent, with several being
highly correlated. Nominally significant correlations (Puncorrected<0.05) were found with a
number of traits (Table 3).
Both epigenetic age acceleration measures had nominally significant positive genetic corre-
lations with a range of traits pertaining to adiposity, and negative correlations with father’s age
at death and childhood IQ. Nominally significant genetic correlations were observed between
Hannum-EAA, but not Horvath-EAA, and a wide range of traits including measures relating
to education, smoking behaviour, various lipid- and cholesterol-related measures, diabetes
and related glycemic measures, and parent’s age at death. Some of these results have previously
been reported [19,20], but many are novel. The current study did, however, fail to replicate a
number of previously reported correlations, including with age at menopause [20]. Details of
the genetic correlations of all the tested traits with Horvath-EAA and Hannum-EAA are given
in S17 Table and S18 Table, respectively.
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Table 3. Nominally significant genetic correlations (Puncorrected<0.05) between Horvath-EAA/Hannum-EAA and other health and behavioural traits.
Phenotype Trait Genetic Correlation SE P-value
Horvath-EAA Fathers age at death -0.472 0.144 0.001
Urate 0.278 0.089 0.002
Waist-to-hip ratio 0.194 0.064 0.002
Waist circumference 0.178 0.064 0.005
ICV -0.403 0.163 0.013
Forced expiratory volume in 1 second (FEV1)/Forced Vital capacity(FVC) -0.170 0.078 0.030
Extreme waist-to-hip ratio 0.306 0.146 0.036
Child birth weight -0.274 0.131 0.037
Childhood IQ -0.317 0.152 0.037
Leucine 0.450 0.222 0.043
Glycoprotein acetyls; mainly a1-acid glycoprotein 0.360 0.183 0.049
Hannum-EAA Waist-to-hip ratio 0.225 0.062 0.0003
Waist circumference 0.210 0.067 0.002
Parents age at death -0.455 0.148 0.002
Type 2 Diabetes 0.331 0.114 0.004
Years of schooling 2013 -0.231 0.083 0.005
Years of schooling 2016 -0.162 0.058 0.006
Birth weight 0.211 0.079 0.007
HDL cholesterol -0.210 0.082 0.010
Former vs Current smoker -0.330 0.130 0.011
Forced expiratory volume in 1 second (FEV1) -0.239 0.095 0.012
Forced expiratory volume in 1 second (FEV1) -0.371 0.149 0.013
Hip circumference 0.163 0.066 0.013
Intelligence -0.169 0.070 0.016
Cigarettes smoked per day 0.326 0.138 0.018
Ever vs never smoked 0.202 0.088 0.022
College completion -0.195 0.086 0.023
Age of first birth -0.156 0.070 0.026
HOMA-B 0.305 0.137 0.026
Fasting insulin main effect 0.237 0.107 0.027
HbA1C -0.277 0.126 0.028
Childhood IQ -0.286 0.130 0.028
Fathers age at death -0.287 0.131 0.028
Triglycerides 0.136 0.065 0.036
Phospholipids in medium LDL -0.410 0.200 0.040
Free cholesterol in large LDL -0.485 0.237 0.041
Anorexia Nervosa -0.152 0.074 0.041
Amyotrophic lateral sclerosis 0.363 0.178 0.042
Obesity class 1 0.135 0.067 0.042
Years of schooling (proxy cognitive performance) -0.171 0.084 0.042
Phospholipids in large LDL -0.471 0.232 0.043
Phospholipids in very small VLDL -0.373 0.184 0.043
Free cholesterol in IDL -0.439 0.220 0.046
Celiac disease -0.265 0.134 0.047
Extreme waist-to-hip ratio 0.285 0.145 0.048
(Continued)
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Discussion
This study investigated genetic markers of epigenetic ageing in a sample of 13,493 individuals
of European ancestry. We examined genetic determinants of both Horvath-based (adjusted for
the composition of age-related blood cells) and Hannum-based (immune system-associated)
epigenetic age acceleration, sometimes referred to as ‘intrinsic’ and ‘extrinsic’ epigenetic age
acceleration, to gain insight into the regulation of epigenetic ageing. We report several novel
findings in addition to replicating a sub-set of previous results. The meta-analysis of Horvath-
EAA identified ten independent associated SNPs, doubling the number reported to date, and
highlighted 21 genes involved in Horvath-based epigenetic ageing. A single genome-wide sig-
nificant variant was identified for Hannum-EAA, along with 12 implicated genes. We uncov-
ered limited evidence of functionality within some associated genomic loci, with many SNPs
located in regions of open chromatin and a smaller number in regulatory regions. Some loci
also contained regions where genetic variation is predicted to be deleterious.
It has been hypothesised that in some cases DNA methylation could be a candidate mecha-
nism for mediating genetic effects on ageing-related phenotypes [54]. Intriguingly, four of the
ten Horvath-EAA-associated SNPs are mQTL for CpGs used in the Horvath/Hannum epige-
netic clocks. A possible interpretation of this is that the functional mechanism by which these
SNPs influence the rate of biological ageing is via altering methylation levels.
A number of the genes significantly associated with Horvath-EAA are related to metabo-
lism (NHLRC1, TPMT, KDM1B, and ESYT3), consistent with several studies reporting pheno-
typic associations between Horvath-based EAA and metabolic syndrome characteristics and
supporting the suggestion of a role in tracking metabolic ageing [15,19]. Others are involved
in immune system pathways (TRIM59, KPNA4, EDARADD), while several have roles in cellu-
lar processes linked to ageing: apoptosis and autophagy (FAIM), ageing and autophagy
(TERT), and coordinating vital cell functions (PIK3CB). PIK3CB plays a role in the signal
transduction of insulin and insulin-like pathways [55], and genetic variants at this locus have
been related to insulin-like growth factor levels in plasma, and human longevity [56].
Genes associated with Hannum-based EAA, often referred to as immune system ageing,
include several involved in innate immune system pathways (e.g. TRIM46 and MUC1) or with
metabolic and immune system functions (MANBA, UBE2D3). Other associated genes of inter-
est include those with roles relating to ageing and longevity: MTRNR2L7 is a neuroprotective
and anti-apoptotic factor, and CISD2 regulates autophagy and is a fundamentally important
regulator of lifespan. Mouse studies indicate that CISD2 ameliorates age-associated degenera-
tion of skin, skeletal muscle, and neurons, protects mitochondria from age-related damage
and functional decline, and attenuates age-associated reduction in energy metabolism [57],
while CISD2 deficiency leads to a number of phenotypic features suggestive of premature age-
ing [58].
Our LD score regression analysis replicated the positive genetic correlations with central
adiposity reported by Lu et al. (2018) at nominal significance levels, supporting the suggestion
Table 3. (Continued)
Phenotype Trait Genetic Correlation SE P-value
Total cholesterol in large LDL -0.430 0.219 0.049
Genetic correlations were determined using bivariate Linkage Disequilibrium score regression implemented in the online software LD Hub. SE is the standard error of
the genetic correlation estimate; P-value is the association P-value for the genetic correlation estimate; ICV–intracranial volume; LDL–low density lipoprotein; IDL–
intermediate density lipoprotein; VLDL–very low density lipoprotein.
https://doi.org/10.1371/journal.pgen.1008104.t003
GWAS of epigenetic age acceleration
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008104 November 18, 2019 15 / 30
that observed phenotypic associations [15,19] may result in part from a shared genetic aetiol-
ogy. We did not, however, replicate previously reported correlations between Horvath-EAA
and metabolic disease-related traits or diabetes, and found these traits to be correlated with
Hannum-EAA at only nominal significance levels in our larger sample [20]. We also found no
correlation between epigenetic age acceleration and age at menopause. Nominally significant
genetic correlations between Hannum-based, but not Horvath-based, epigenetic age accelera-
tion, and lifestyle factors such as smoking behaviour and education level, provide some evi-
dence for a genetic basis underlying the phenotypic results we reported previously [19], and
provide tentative support for the hypothesis that Hannum-based epigenetic ageing is relatively
sensitive to changes in environment and lifestyle. Father’s age at death, a rough proxy for life-
span [59], was nominally significantly correlated with both EAA measures, and parents’ age at
death was additionally correlated with Hannum-EAA, consistent with a body of work demon-
strating robustly that EAA predicts life span [10,12]. Aside from these, genetic correlations
with age-related traits were surprisingly few: it is possible that this could reflect an overly con-
servative correction for the multiple tests carried out, or low statistical power, rather than a
genuine lack of correlations (S4 Table). While the mean χ2 values (1.059 and 1.054 for Hor-
vath-EAA and Hannum-EAA respectively) indicate a sufficient level of polygenicity within the
dataset for use with LD score regression, the heritability Z-scores for Horvath-EAA and Han-
num-EAA are 3.69 and 4.91 respectively. The recommendation is that genetic correlation anal-
ysis should be restricted to GWAS with a heritability Z-score of 4 or more, on the grounds of
interpretability and power [53], so the Horvath-based results particularly should be interpreted
with caution.
This study of epigenetic age acceleration benefits from having a large sample size. Increas-
ing GWAS sample size increases the power to detect associated loci, and is often achieved, as
in this case, by combining smaller studies in a meta-analysis. Meta-analytic GWAS are, how-
ever, sometimes hampered by differences in how a trait is measured between individual stud-
ies. In this instance, use of the online calculator to calculate the EAA measures and using the
same algorithm and output columns for each study, mitigates this. The current study com-
prises only individuals of European ancestry, which confers a further advantage as epigenetic
ageing rates have been shown to differ between ethnicities [60].
Despite the large sample overlap, some results of this study differ from those reported by Lu
et al. (2018). One reason for this could be that only European-ancestry individuals were
included in this analysis whereas the Lu study reports results from a mixed ancestry sample.
Another likely contributing factor is the age ranges involved: the GS cohort, not included in
Lu’s analysis but which makes up 38% of the total sample in the current study, has a mean age
of 48.5 years, 14.4 years younger than the mean age of the remaining cohorts. Given that epige-
netic age changes over the life course, although not necessarily in parallel with chronological
age, this could help explain the discrepancies between the studies.
There are a number of limitations which should be considered when interpreting the results
of this study. This is the largest meta-analysis of genetic determinants of epigenetic age acceler-
ation to date, however, while large for these phenotypes, the size of the sample studies here is
still small in terms of genome-wide analysis of polygenic traits. As only European-ancestry
individuals were included, the results are not generalisable to other ethnicities. The MAGMA
gene-based analysis identified a number of biologically plausible associated genes for both
EAA measures; however, while many of these genes are located in the same genomic regions
as the significantly associated SNPs, this should not be taken as evidence that the SNP associa-
tion is effected through the gene. Identifying effector transcripts for GWAS variants is a diffi-
cult and as yet unresolved problem, and our knowledge of how these genes may affect the
activity of the SNPs is limited. In addition, MAGMA does not take into account information
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from methylation QTL to help identify relevant genes; future work should place more empha-
sis on the role of mQTL. The lack of significant genetic correlations between EAA and age-
related traits may reflect low statistical power (the heritability Z-score of 3.69 for Horvath-
EAA falls below the recommended lower threshold of 4 for genetic correlation analysis) or
overly stringent correction for multiple comparisons (FDR correction was applied over the
218 tested traits, however not all of these were independent) rather than a true absence of
shared genetic aetiology. Finally, while we have identified a number of SNPs and genes signifi-
cantly associated with EAA, including genes already known to be related to ageing, the analy-
ses presented here fall short of providing a mechanistic explanation for how these variants and
genes act to influence biological age. This study should be considered as ’discovery’ research,
with a comprehensive investigation of the functional and biological mechanisms behind the
SNP and gene associations being a direction for future work.
Horvath-based and Hannum-based epigenetic age acceleration are thought to represent
different aspects of ageing. Hannum-EAA has been described as a biomarker of immune
system ageing, and has been found to be associated with a wide range of traits [15,19], indi-
cating a sensitivity to variations in environment and lifestyle. By contrast, Horvath-EAA is
considered to be a fundamental, intrinsic cellular ageing process, largely unrelated to life-
style factors, although associations with a range of metabolic syndrome characteristics sug-
gest a role in tracking metabolic ageing processes. Our results reflect this to a large degree,
with more nominally significant genetic correlations found with Hannum-EAA than Hor-
vath-EAA, including items relating to education, smoking, intelligence, and various choles-
terol measures. Meanwhile the greater number of significant variants, genomic loci, and
genes associated with Horvath-EAA are consistent with the hypothesis that this measure of
’cell-intrinsic’ ageing is less related to lifestyle and more under genetic control, and thus
more likely to remain relatively stable. Despite these differences, however, our results indi-
cate some common features. The significant genetic correlation of 0.57 between the two
measures suggests a moderate overlap in the genetic factors influencing the two phenotypes
despite the biomarkers being based on almost entirely distinct CpG sets. Both also appear to
be influenced by genes associated with metabolic and immune system pathways, although
the specific genes involved are different.
Conclusions
This study provided insight into the genetic determinants of differential biological ageing
through the identification of genes and genetic variants associated with epigenetic age acceler-
ation. We doubled the number of SNPs associated with Horvath-EAA reported to date, and
report 21 genes significantly associated with this phenotype, including PIK3CB, linked to
human longevity. We identified 12 Hannum-EAA-associated genes, one of which, CISD2, has
a fundamental role in lifespan control. Our results also highlighted differences in the genetic
architecture of the Horvath-based and Hannum-based EAA measures, with no genome-wide
significant SNPs or genes common to the two, providing substantial support for the hypothesis
that they represent different aspects of ageing.
While the genetic information coded by our DNA sequence remains largely fixed through-
out the lifetime, the expression of our genes is primarily regulated by epigenetic factors, which
change over time. Epigenetic age increases with, but not in parallel with, chronological age;
individual differences in the rate of epigenetic ageing potentially explain why trajectories of
ageing differ between individuals. Understanding what causes these differences could poten-
tially inform therapeutic interventions to delay the onset of age-related decline and improve
ageing outcomes.
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Methods
Ethics statement
Generation Scotland received ethical approval from the NHS Tayside Committee on Medical
Research Ethics (REC Reference Number: 05/S1401/89). GS has also been granted Research
Tissue Bank status by the Tayside Committee on Medical Research Ethics (REC Reference
Number: 10/S1402/20), providing generic ethical approval for a wide range of uses within
medical research. All participants provided written informed consent. Details of ethics
approval and consent to participate for the cohorts included in the Lu et al. (2018) study can
be found in their publication.
Generation Scotland cohort
We carried out genome-wide association analyses of Horvath-EAA and Hannum-EAA in a
subset of individuals (n = 5,100) from the Generation Scotland: Scottish Family Health Study
(GS) for whom both genetic and DNA methylation data were available. GS is a family- and
population-based cohort recruited via general medical practices across Scotland; the recruit-
ment protocol and sample characteristics are described in detail elsewhere [61,62]. In brief, the
full cohort comprises 23,960 individuals aged between 18 and 98 years. Pedigree information
was available for all participants, detailed socio-demographic and clinical data were collected,
and biological samples were taken for genotyping.
DNA methylation and derivation of epigenetic age acceleration variables in
GS
DNA methylation data were obtained from peripheral blood (n = 5,091) or saliva (n = 10) sam-
ples for 5,101 individuals from GS, with quality control checks carried out using standard
methods outlined in S1 Text, and described in full elsewhere [19]. After quality control (QC),
the dataset comprised beta-values for 860,928 methylation loci. Methylation-based age esti-
mates (DNAm age) and epigenetic age acceleration variables (Horvath-EAA and Hannum-
EAA, described in S1 Text) were obtained from the online DNA Methylation Age Calculator
(https://dnamage.genetics.ucla.edu/) developed by Horvath [8]. Normalised DNA methylation
beta-values were submitted to the calculator, using the ’Advanced Analysis for Blood Data’
option, and undergoing further normalisation within the calculator algorithm to make the
data comparable to the training data of the epigenetic clock. One individual was flagged by the
calculator as having a gender mismatch, and was therefore omitted from downstream analysis,
leaving a total of 5,100 individuals for the GWAS of Horvath-EAA and Hannum-EAA in GS.
Blood cell abundance measures were also estimated by the online calculator, based on DNA
methylation levels, as described previously [63].
Genotyping, imputation, and quality control in GS
An overview of biological sample collection, DNA extraction, genotyping, imputation using
the Haplotype Research Consortium reference panel (v1.1), and quality control for GS is
included in S1 Text; full details have been described previously [64]. A total of 20,032 individ-
uals passed all quality control thresholds. Following the removal of monomorphic or multialle-
lic variants and SNPs with a low imputation quality or a minor allele frequency below 1%, an
imputed dataset with 8,633,288 hard called variants remained to be used in the genome-wide
association analysis.
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GWAS of Horvath-EAA and Hannum-EAA in GS
GWAS of Horvath-EAA and Hannum-EAA in GS were conducted using mixed linear model
based association (MLMA) analysis [65], implemented in GCTA (Genome-wide Complex
Trait Analysis) (v1.25) [66], and adjusting for sex to account for the higher epigenetic age
acceleration in men than in women [7,12,60]. In order to account for population stratification,
it is common to conduct ancestry-informative principal components analysis on the popula-
tion in question, and use a number of the top-ranking principal components (PCs) from this
analysis as covariates in the GWAS. However, as GS is a family-based sample, we employed a
different approach to capture population structure. In place of PCs, two genomic relationship
matrices (GRMs) were included in the GWAS, as this method has been shown to account for
potential upward biases due to excessive relationships, and thus allows the inclusion of closely
and distantly related individuals in genetic analyses [67]. The first GRM included pairwise
relationship coefficients for all individuals, while the second had off-diagonal elements <0.05
set to 0; full details of the methods involved and construction of the GRMs is given elsewhere
[68]. The results of univariate LD score regression analysis [26] (S4 Table) indicate that the
two GRMs adequately accounted for population stratification, so it was not necessary to
include ancestry-informative PCs in the GWAS.
GWAS meta-analysis of Horvath-EAA and Hannum-EAA
We obtained summary statistics from the largest European-ancestry analysis of epigenetic age
acceleration to date (n = 8,393, Lu et al., 2018, summary information in S19 Table), and meta-
analysed these with GS (details above). We chose not to include available data from non-Euro-
pean samples, despite the advantages of increased sample size, as different ethnicities have
been shown to have different epigenetic ageing rates [60]. Association summary statistics from
the GWAS of the two EAA phenotypes in GS and the Lu et al. study were meta-analysed using
the inverse variance-weighted approach, which weights effect sizes by sampling distribution.
This analysis was implemented in METAL [69], conditional on each variant being available in
both samples. As SNPs which co-located with CpGs from the Hannum- or Horvath-based
DNAm age predictors had already been excluded from Lu et al.’s analysis, it was not necessary
to repeat this step. This resulted in 5,932,107 genetic variants for Horvath-EAA and 5,931,171
variants for Hannum-EAA, in a meta-analysis dataset containing 13,493 participants.
The meta-analytic summary statistics produced by METAL were uploaded to FUMA
(fuma.ctglab.nl) [27], which identified index SNPs and genomic risk loci related to epigenetic
age acceleration. FUMA selects independent significant SNPs based on their having a genome-
wide significant P-value (P<5x10-8) and being independent from each other (r2<0.6 by
default) within a 250kb window. The European subset of the 1000 Genomes phase 3 reference
panel [70] was used to map LD. SNPs in LD with these independent significant SNPs (r2�0.6)
within a 250kb window, and which have a minor allele frequency (MAF)>1% within the 1000
Genomes reference panel, were included for further annotation and used for gene prioritiza-
tion. A subset of the independent significant SNPs, those in LD with each other at r2<0.1
within a 250kb window, were identified as lead SNPs. Genomic risk loci, including all indepen-
dent signals that were physically close or overlapping in a single locus, were identified by
merging any lead SNPs that were closer than 250kb apart (meaning that a genomic risk locus
could contain multiple lead SNPs, with each locus represented by the lead SNP with the lowest
P-value in that locus).
Conditional analysis was implemented using GCTA software [66] to ascertain whether
associated genetic loci harboured more than one independent causal variant, conditioning on
the lead SNP at the locus and using GS as the reference panel for inferring the LD pattern.
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SNPs which remained significantly associated (P<5x10-8) with the phenotype after condition-
ing on the lead SNP were considered to be further independent associated variants.
Manhattan plots and quantile-quantile plots were generated in R version 3.2.3 using the
’qqman’ package, and regional SNP association results were visualised with LocusZoom [21].
SNPs which surpassed the threshold for genome-wide significance in our meta-analyses were
checked against the NHGRI-EBI catalog of published GWAS [71,72] (www.ebi.ac.uk/gwas/) to
determine whether they had previously been observed in association analysis.
Methylation quantitative trait loci
To ascertain whether the genome-wide significant associations from the Horvath-EAA and
Hannum-EAA GWAS are confounded by methylation quantitative trait loci, we checked for
SNP-CpG pairings in the mQTL database, a catalogue of the genetic influences on DNA meth-
ylation (mQTLdb, [25]). The independent significant SNPs from both GWAS were input to
the database, using the MatrixEQTL database setting, which contains all associations below
1x10-7, and assessing all five time points (birth, adolescence, childhood, middle age, and preg-
nancy). A distance greater than or equal to 1 Mb was considered to be trans.
Heritability analysis
To estimate the SNP-based heritability for Horvath-EAA and Hannum-EAA, univariate Link-
age Disequilibrium score regression [26] was applied to the GWAS summary statistics for both
measures. This method also provides metrics to evaluate the proportion of inflation in the test
statistics caused by confounding biases such as residual population stratification, relative to
genuine polygenicity. We used pre-computed LD scores, estimated from the European-ances-
try samples in the 1000 Genomes Project [73].
SNP functional annotation
Functional annotation, using all SNPs located within the genomic risk loci which were nomi-
nally significant (P<0.05), had a MAF�1%, and were in LD of r2�0.6, was carried out in
FUMA v1.3.0 [27]. In order to investigate the functional consequences of variation at these
SNPs, they were first matched (based on chromosome, base pair position, reference and non-
reference alleles) to a database containing functional annotations from a number of
repositories:
• ANNOVAR (Annotate Variation) categories [74], used to identify a SNP’s function and
determine its position within the genome.
• Combined Annotation Dependent Depletion (CADD) scores [28], a measure of the deleteri-
ousness of genetic variation at a SNP to protein structure and function, with higher scores
indicating more deleterious variants.
• RegulomeDB (RDB) scores [29], based on data from eQTL as well as chromatin marks, with
lower scores given to variants with the greatest evidence for having regulatory function.
• Chromatin states [75–77], indicating the level of accessibility of genomic regions, described
on a 15 point scale, where lower chromatin scores indicate a greater level of accessibility to
the genome at that site; generally, between 1 and 7 is considered an open chromatin state.
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Gene-based analysis
Gene-based analysis was performed for each phenotype using the results of our association
analysis, using default settings in MAGMA v1.6 [39], integrated within the FUMA web appli-
cation. Summary statistics of SNPs located within protein-coding genes were aggregated to
assess the simultaneous effect of all SNPs in the gene on the phenotype. The European panel of
the 1000 Genomes phase 3 data was used as a reference panel to account for LD [70]. Genetic
variants were assigned to protein-coding genes obtained from Ensembl build 85, resulting in
17,798 genes being analysed. After Bonferroni correction (α = 0.05/17,798), a threshold for
genome-wide significant genes was defined at P<2.809×10−6.
eQTL and colocalisation analysis
The independent genome-wide significant SNPs identified in the meta-analyses of Horvath-
EAA and Hannum-EAA were assessed to determine whether they were potential eQTL, by
mapping SNPs to genes if allelic variation at the SNP is associated with expression levels of the
gene. This analysis was carried out using data from the Genotype Tissue Expression portal
(GTEx) v7 [30], integrated within the FUMA web application. GTEx uses gene expression data
from 48 different types of human tissue, linked to genotype data to provide information on
eQTL. Since Horvath-EAA is derived from the pan-tissue Horvath epigenetic clock, eQTL
analysis of the ten Horvath-EAA-associated SNPs used all the available tissue types in GTEx.
Analysis for the Hannum-EAA SNP, however, was restricted to only the blood tissue types, as
the Hannum epigenetic clock is specific to blood samples. eQTL mapping carried out within
FUMA maps SNPs to genes which likely affect expression of those genes within 1Mb, i.e. cis-
eQTL. Although FUMA contains all SNP-gene pairs of cis-eQTL, including non-significant
associations, we limited our analysis to significant SNP-gene pairs, with a false discovery rate
(FDR)� 0.05 used as the cut-off to define significant eQTL associations.
To further investigate the potential regulatory functions of the identified SNPs, we carried
out colocalisation analysis to determine whether the SNPs are mediated through gene expres-
sion. We integrated our GWAS results with cis-eQTL data from the eQTLGen Consortium
(https://www.eqtlgen.org/) [38], using a Bayesian method, ’coloc’ [37], which evaluates
whether the GWAS and eQTL associations best fit a model in which the same SNP is associ-
ated with both EAA and cis gene expression. This method, implemented in the ’coloc’ package
in R, tests pairwise colocalisation of SNPs in significant genomic regions in the GWAS with
eQTLs, and generates posterior probabilities for each locus by weighing the evidence for com-
peting hypotheses of no causal variants for either trait, causal variants for one trait only, inde-
pendent causal variants influencing the two traits, or a shared causal SNP. We extracted
summary statistics from the Horvath-EAA/Hannum-EAA meta-analytic GWAS results for all
SNPs in a +/- 200 kb region around each genome-wide significant SNP, and extracted equiva-
lent summary data for the same region in the eQTL analysis. Using the default prior probabili-
ties in ‘coloc’, pairwise colocalisation was then tested between each GWAS-eQTL pair, with a
posterior probability of�0.95 considered to be strong evidence in favour of a given
hypothesis.
Gene-set analysis
To assess whether the Horvath-EAA and Hannum-EAA GWAS meta-analysis results are
enriched for various gene-sets and provide insight into the involvement of specific biological
pathways in the genetic aetiology of the phenotype, the gene-based analysis results were used
to perform competitive gene-set and pathway analysis using default parameters in MAGMA
v1.6, integrated within FUMA. The reference genome was 1000 genomes phase 3. This analysis
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used gene annotation files from the Molecular Signatures Database v5.2 for "Curated gene
sets", covering chemical and genetic perturbations, and Canonical pathways, and "GO terms",
covering three ontologies: biological process, cellular components, and molecular function. A
total of 10,894 gene-sets were examined for enrichment in Horvath-EAA and Hannum-EAA,
with a Bonferroni correction applied to control for multiple testing. Thus genome-wide signif-
icance was defined at P = 0.05/10,894 = 4.59x10-6.
Genetic correlations
Cross trait LD score regression [52] was used to calculate genetic correlations between Hor-
vath-based and Hannum-based EAA in our meta-analysis, and then between Horvath-EAA/
Hannum-EAA and 218 other behavioural and disease-related traits for which GWAS sum-
mary data were available through LD Hub [53]; traits derived from non-Caucasian or mixed
ethnicity samples were removed prior to analysis. This method exploits the correlational struc-
ture of SNPs across the genome and uses test statistics provided from GWAS summary esti-
mates to calculate the genetic correlations between traits [52]. We checked whether our meta-
analysis datasets had sufficient evidence of a polygenic signal, indicated by a heritability Z-
score of>4 and a mean χ2 statistic of>1.02 [52]. By default, a MAF filter of>1% was applied,
and indels and strand ambiguous SNPs were removed. We filtered to HapMap3 SNPs, and
SNPs whose alleles did not match those in the 1000 Genomes European reference sample were
removed. LD scores and weights for use with European populations were downloaded from
(https://github.com/bulik/ldsc). We did not constrain the intercepts in our analysis, as we
could not quantify the exact amount of sample overlap between cohorts. False discovery rate
correction was applied across the 218 traits to correct for multiple testing [78].
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